Assets Available for Licensing

XOMA Royalty was a traditional biotech company for over 35 years.  In 2017, we transformed our business operations, exiting the traditional biotech activities of discovery, research and development.

Asset 1
Phage Display Platform

Due to our legacy, we have one of the largest phage display libraries in the industry, which is available for licensing.

Email XOMA

© 2026 XOMA Royalty Corporation.  All rights reserved.

Follow us:

Linkedin Twitter

All references to “portfolio” on this website refer strictly to milestone and/or royalty rights associated with a basket of drug products in development.  All references to “assets” on this website refer strictly to milestone and/or royalty rights associated with individual drug product candidates in development.  References to royalties or royalty rates strictly refer to future potential payment streams regardless of whether or not they are technically defined as royalties in the underlying contractual agreement; further, any rates referenced herein are subject to potential future contractual adjustments.